Page last updated: 2024-11-05

fr 74366 and Chronic Illness

fr 74366 has been researched along with Chronic Illness in 2 studies

Research Excerpts

ExcerptRelevanceReference
"45 mug equiv/g, respectively, when dosed with [(14)C]lidorestat at 10 mg/kg po)."1.33Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications. ( Dicioccio, AT; Geraci, LS; Gunn, DE; Jacot, JL; Jones, JH; Jones, ML; Mitschler, A; Petrova, T; Podjarny, AD; Sawicki, DR; Sredy, J; Van Zandt, MC, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Van Zandt, MC1
Jones, ML1
Gunn, DE1
Geraci, LS1
Jones, JH1
Sawicki, DR1
Sredy, J1
Jacot, JL1
Dicioccio, AT1
Petrova, T1
Mitschler, A1
Podjarny, AD1
Greene, DA1
Stevens, MJ1
Feldman, EL1

Reviews

1 review available for fr 74366 and Chronic Illness

ArticleYear
Diabetic neuropathy: scope of the syndrome.
    The American journal of medicine, 1999, Aug-30, Volume: 107, Issue:2B

    Topics: Aldehyde Reductase; Animals; Chronic Disease; Controlled Clinical Trials as Topic; Diabetic Foot; Di

1999

Other Studies

1 other study available for fr 74366 and Chronic Illness

ArticleYear
Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications.
    Journal of medicinal chemistry, 2005, May-05, Volume: 48, Issue:9

    Topics: Aldehyde Reductase; Animals; Cataract; Chronic Disease; Crystallography, X-Ray; Diabetes Complicatio

2005